Genzyme's Larry Blankstein looks at the challenges of completing global clinical trials on time and effectively.
Certain tactics in pharmaceutical marketing have tarnished the industry's reputation in recent times. Todd Evans of PwC looks at the new thinking that can help restore the public trust.